Sorted news

Successful phase 3 trial of drug for liver cancer

An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma (HCC), a form of liver cancer, giving people who previously had no other options a better ...

10 hours ago
popularity2 comments 0